Eye Shields for NFL Players, COVID-19’s Impact on Vision Scientists, and More
Demographic and Clinical Features of MIGS Recipients
Pegcetacoplan Carries Risk of New Exudation
Eye Shields for NFL Players
MEWDS Misdiagnosis Is Common
American Journal of Ophthalmology
Return to OR After RD Repair: Revisiting the 45-Day Metric
Screen Use and Meibomian Gland Atrophy in Children
COVID-19’s Potential Impact on Vision Scientists
Sequential Bilateral Cataract Surgery and Refractive Outcomes
ICD-10 Codes for Uveitis: EHR Discrepancies
SARS-CoV-2: RNA Genomics in Ocular Specimens
Outcomes of RRD Repair
IRIS Registry Data Snapshot: Patient Visits During the Pandemic
On March 18, 2020, the Academy sent a recommendation to “cease providing any treatment other than urgent or emergent care immediately” via email to members. In the month following that email, patient visits declined by more than 70% compared with baseline.
To assess the impact of the COVID-19 pandemic on patient care and outcomes, Leng et al. evaluated data from the IRIS Registry. Their earlier analysis covered January through August 2020.1 A new snapshot (right) updates their findings with data through December 2020. By mid-June, patient visits stabilized to 85%-95% of baseline, representing a substantial but not full recovery, possibly because vaccines were not available until the end of the year.
1 Leng T et al. Ophthalmology. Published online June 15, 2021.
COVID IMPACT. Daily weekday (nonholiday) patient visit volume during 2020. Secondary y-axis shows visit volume compared to a baseline from Jan. 1 to March 17, 2020. Note: The Academy has partnered with Verana Health to curate and analyze IRIS Registry data.